Increased leukocyte adhesion to vascular endothelium in preeclampsia is inhibited by antioxidants

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 4, 2007, Pages 400.e1-400.e8

  Ryu, Seongho ^a   Huppmann, Alison R ^a   Sambangi, Nirmala ^a   Takacs, Peter ^a   Kauma, Scott W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adhesion; antioxidants; endothelium; leukocyte; preeclampsia

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BISINDOLYLMALEIMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ADULT; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE ADHERENCE; LEUKOCYTE ENDOTHELIUM ADHESION ASSAY; MALE; MICROVASCULARIZATION; MONOCYTE; PREECLAMPSIA; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 33947667758     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.12.023     Document Type: Article

References (30)

1. Sibia B.M. Hypertension in pregnancy. In: Gabbe S.G., Niebyl J.R., and Simpson J.L. (Eds). Obstetrics: normal & problem pregnancies. 3rd ed. (1996), Churchill Livingstone, New York
2. Roberts J.M. Pregnancy-related hypertension. In: Creasy R.K., and Resnik R. (Eds). Maternal-fetal medicine: principles and practice. 2nd ed. (1989), WB Saunders, Philadelphia
3. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
4. Roberts J.M., Taylor R.N., and Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol 15 (1991) 86-93
5. Kunsch C., and Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85 (1999) 753-766
6. Myatt L., and Miodovnik M. Prediction of preeclampsia. Semin Perinatol 23 (1999) 45-57
7. Staff A.C., Ranheim T., Khoury J., and Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 180 (1999) 587-592
8. Zeek P.M., and Assali N.S. Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol 20 (1950) 1099-1109
9. Takacs P., Kauma S.W., Sholley M.M., Walsh S.W., Dinsmoor M.J., and Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-κB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 15 (2001) 279-281
10. Kauma S., Takacs P., Scordalakes C., Walsh S., Green K., and Peng T. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 100 (2002) 706-714
11. Takacs P., Green K.L., Nikaeo A., and Kauma S.W. Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol 188 (2003) 740-744
12. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
13. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
14. Roy S., Sen C.K., Kobuchi H., and Packer L. Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. Free Radic Biol Med 25 (1998) 229-241
15. Wallukat G., Homuth V., Fischer T., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103 (1999) 945-952
16. ACOG Committee on Practice Bulletins-Obstetrics. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin 33. Obstet Gynecol 99 (2002) 159-167
17. Sholley M.M., Gudas S.A., Schwartz C.C., and Kalimi M.Y. Dehydroepiandrosterone and related steroids induce multilamellar lipid structures in cultured human endothelial cells. Am J Pathol 136 (1990) 1187-1199
18. Hubel C.A., McLaughlin M.K., Evans R.W., Hauth B.A., Sims C.J., and Roberts J.M. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 174 (1996) 975-982
19. Lorentzen B., and Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 33-39
20. Walsh S.W. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16 (1998) 93-104
21. Davidge S.T. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 16 (1998) 65-73
22. Diedrich F., Renner A., Rath W., Kuhn W., and Wieland E. Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation. Am J Obstet Gynecol 185 (2001) 166-172
23. Wang Y.P., Walsh S.W., Guo J.D., and Zhang J.Y. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 165 (1991) 1695-1700
24. Chappell L.C., Seed P.T., Briley A., et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 187 (2002) 127-136
25. Jonsdottir L.S., Arngrimsson R., Geirsson R.T., Sigvaldason H., and Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 74 (1995) 772-776
26. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 (1999) 718-723
27. Chappell L.C., Seed P.T., Briley A.L., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354 (1999) 810-816
28. Poston L., Briley A., Seed P.T., Kelly F.J., and Shennan A.H. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet 367 (2006) 1145-1154
29. Paoletti R., Gotto Jr. A.M., and Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 109 23 Suppl 1 (2004) III20-III26
30. Haller H., Hempel A., Homuth V., et al. Endothelial-cell permeability and protein kinase C in pre-eclampsia. Lancet 351 (1998) 945-949